E-ISSN: 2314-7326
P-ISSN: 2314-7334
Journal of Neuroinfectious Diseases
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Role of Immunological Markers in the Diagnosis, Treatment and Follow-Up of Human Neurocysticercosis

Visit for more related articles at Journal of Neuroinfectious Diseases

Abstract

Neurocysticercosis is the commonest parasitic disease of the nervous system. Its clinical manifestations are highly variable ranging from asymptomatic disease to recurrent seizures and multisystem involvement. The imaging findings of neurocysticercosis although typical are not diagnostic for the disease and can be confused lesions of tuberculomas. To circumvent the diagnostic difficulty various serological tests have been tried. Most of the early serological tests were limited by low sensitivity and specificity for the diagnosis. Recently better antibody based assays like Enzyme Linked Immuno Electro Transfer Blot (EITB) have vastly improved the specificity of diagnosis, but sensitivity esp. in single cystic lesions still remains suboptimal. Further advances in the field of serodiagnosis of neurocysticercosis, especially focusing on validation of emerging techniques of diagnosis, will be required before the can be implemented for routine use.

--
Post your comment

Share This Article

Article Usage

  • Total views: 13032
  • [From(publication date):
    June-2014 - Sep 19, 2024]
  • Breakdown by view type
  • HTML page views : 8711
  • PDF downloads : 4321
Top